Connect Biopharma is trading at $2.20 (5.3% up) following a modest regular-session gain and a stronger move in after-hours trading.
- The price action appears aligned with a risk-on tape as major U.S. indices rallied during the session.
- There are no fresh company-specific news or earnings reports today to account for the move.
- Market analysts have previously tied upside in the name to broad market momentum rather than specific fundamental catalysts.